Prof. Dr. re. medical habil. Karel Kostev MA
ORCID: 0000-0002-2124-7227
is Scientific Principal and head of the epidemiology team at IQVIA in Frankfurt. He studied sociology and statistics and received his doctorate and habilitation in medicine. He teaches epidemiological and medical subjects at the University Hospital in Marburg. His work focuses on health services research in the area of chronic illnesses.
Articles
- Untersuchung des Nutzens des Check-up 35 zur Früherkennung von Zielerkrankungen in Deutschland
MVF 05/26
- Reduktion von Analgetika-Verschreibungen durch intraartikuläre Hyaluronsäure bei Kniegelenksarthrose
MVF 04/26
- Zusammenhang zwischen einer Therapie mit SGLT2-Inhibitoren und Demenz bei älteren Erwachsenen mit Typ-2-Diabetes
MVF 06/25
- Drug therapy for migraine in children by pediatricians in Germany – what role do discount agreements play?
MVF 03/25
- Frequency of sexually transmitted infections in German specialist practices
MVF 01/25
- Hospital mortality in patients with and without dementia
MVF 06/24
- Proton pump inhibitors (PPIs) in Germany: Status quo of a growing market
MVF 05/24
- Hospital mortality in patients with heart failure in Germany – cross-sectional study
MVF 03/24
- Increase in upper respiratory tract infections following the Covid-19 pandemic
MVF 01/24
- Change in the age structure of newly diagnosed cancer patients between 2010 and 2022 in private practices
MVF 04/23
- Persistence problems in patients with rheumatoid arthritis: How can patient support programs (PSP) help?
Issue 01/2023
- Health insurance-specific differences in persistence among women with breast cancer receiving endocrine therapy (Print)
Issue 06/2022
- No increased risk of venous thrombosis and pulmonary embolism after SARS-CoV-2 vaccination in Germany
Issue 02/2022
- Demographic and clinical characteristics of primary care patients vaccinated against Covid-19 in spring 2021
Issue 06/2021
- What factors are associated with Covid-19 diagnosis in symptomatic patients in primary care practices?
Issue 06/2021
- Increase in depression and anxiety disorder diagnoses during the Covid-19 pandemic among children and adolescents
Edition 04 / 2021
- Which diagnoses are associated with hospital admissions in Germany?
Issue 05/2020
- Changes in the consumption of blood glucose test strips among patients in Germany who use FGM systems
Issue 04/2020
- Adherence to cardiovascular and diabetes therapies before and during the Covid-19 lockdown
Issue 04/2020
- Increased drug purchases by pharmacies from wholesalers in the week before the Covid-19 lockdown
Issue 03/2020
- Drug discount contracts: cost reduction with risks and side effects
Issue 06/2019
- Secondary data analysis on the duration of incapacity for work of depression patients in general practitioner and psychiatric practices
Issue 05/2019
- Prescription prevalence and patterns of painkillers among women in gynecological practices
Issue 01/2020
- Prescription-based prevalence of biologic therapy in patients with psoriasis, rheumatoid arthritis, and inflammatory bowel disease
Issue 04/2019
- Prevalence and treatment of injuries in patients in German general practices
Issue 05/2018
- Association between polypharmacy and initiation of anti-dementia therapy in German general practices
Issue 06/2018
- Risk of depression in osteoporosis patients in German family practices
Issue 03/2017
- Risk factors for mild cognitive impairment in patients in primary care practices
Issue 01/2017
- Hip fracture risk in dementia patients in German general practices
Issue 04/2016
- Changes in the treatment of T2D patients in primary care practices before and after the introduction of new drugs
Issue 03/2016
- Occupational therapy prescriptions for children with developmental disorders from registered child psychiatrists
Issue 02/2015
- Therapy goal of antihypertensive treatment and participation in integrated care programs
Issue 01/2015
- Care profile of patients with occupational therapy prescriptions in private practices
Issue 03/2014
- Significantly shortened survival time of patients with prostate cancer when bone metastases occur
Issue 04/2013
- DDD vs. PDD: Calculation of daily therapy costs using liraglutide as an example
Issue 05/2012
- Insulin glargine and exenatide in type 2 diabetes: A cost comparison in combination with oral antidiabetics
Issue 05/2010
- Analysis of the influence of the doctor on the compliance of breast cancer patients
Issue 02/2013
- Incidence of cardiovascular events in insulin-treated type 2 diabetes patients under real-world care conditions
Issue 01/2012
- The prophylaxis of diabetic foot syndrome is inadequate
Issue 03/2012
- Database-based study of the incidence of coronary heart disease (CHD) in type 2 diabetes patients
Issue 02/2012